Login
Super Investors BROADWOOD CAPITAL INC
BC

BROADWOOD CAPITAL INC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$1.91B
Positions
6
Quarter ended
June 30, 2026
Filed
August 14, 2026

Reported portfolio value by quarter (53 quarters reported)

$2.24B $440M
Q2 13 Q1 16 Q4 18 Q3 21 Q2 24 Q2 26

$440M in Q2 2013 → $1.91B now. Hover for any quarter.

Holdings

As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
MB Monster Beverage Corp New 40.7% Unchanged 8,107,796 $779M
Staar Surgical Co 24.2% Unchanged 16,123,842 $463M
Axon Enterprise Inc 20.3% Unchanged 693,504 $389M
IT Ishares Tr 7.5% Unchanged 474,920 $143M
IM Insight Molecular Dia Inc 3.9% Added 6.3% 12,684,884 $74.8M
LC Lineage Cell Therapeutics In 3.4% Unchanged 49,560,992 $64.9M

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
IM Insight Molecular Dia Inc Added +753,045 +$4.44M 3.9%

Q1 2026

quarter ended March 31, 2026 · filed May 15, 2026

Company Action Shares changed Value of change % of portfolio
Staar Surgical Co Added +1,104,351 +$20.7M 21.3%
UA United Airls Hldgs Inc Exited −150,000 −$16.8M —
AA American Airls Group Inc Exited −820,000 −$12.6M —
SA Southwest Airls Co Exited −183,000 −$7.56M —
Gildan Activewear Inc Exited −112,750 −$7.04M —
MB Monster Beverage Corp New Trimmed −91,200 −$6.61M 41.4%
DA Delta Air Lines Inc Del Exited −52,500 −$3.64M —
IM Insight Molecular Dia Inc Added +521,739 +$1.71M 2.8%
Serina Therapeutics Inc Exited −54,484 −$104K —

Q4 2025

quarter ended December 31, 2025 · filed February 17, 2026

Company Action Shares changed Value of change % of portfolio
Staar Surgical Co Added +1,500,000 +$34.6M 20.4%
Gildan Activewear Inc New +112,750 +$7.04M 0.4%
MB Monster Beverage Corp New Trimmed −51,432 −$3.94M 36.9%
Hanesbrands Inc Exited −1,127,500 −$1.83M —
Serina Therapeutics Inc Trimmed −28,711 −$54.9K —

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
Olo Inc Exited −3,782,821 −$33.7M —
Axon Enterprise Inc Trimmed −760 −$545K 30.0%
MB Monster Beverage Corp New Trimmed −5,000 −$337K 33.4%
Serina Therapeutics Inc Trimmed −2,024 −$10.8K —

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
Staar Surgical Co Added +1,064,227 +$17.9M 14.5%
Olo Inc Added +2,000,487 +$17.8M 2.1%
UA United Airls Hldgs Inc New +150,000 +$11.9M 0.8%
AA American Airls Group Inc New +820,000 +$9.2M 0.6%
SA Southwest Airls Co New +183,000 +$5.94M 0.4%
Hanesbrands Inc New +1,127,500 +$5.16M 0.3%
DA Delta Air Lines Inc Del New +52,500 +$2.58M 0.2%
MB Monster Beverage Corp New Trimmed −40,262 −$2.52M 32.9%
Axon Enterprise Inc Trimmed −1,811 −$1.5M 36.6%

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
Staar Surgical Co Added +1,606,633 +$28.3M 17.8%
O Oncocyte Corp Added +5,165,695 +$15.8M 2.8%
Axon Enterprise Inc Trimmed −26,346 −$13.9M 29.7%
Olo Inc New +1,782,334 +$10.8M 0.9%
IT Ishares Tr Trimmed −45,000 −$8.98M 7.7%
LC Lineage Cell Therapeutics In Added +7,894,737 +$3.57M 1.8%

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Axon Enterprise Inc Trimmed −37,641 −$22.4M 33.5%
O Oncocyte Corp Added +1,315,339 +$3.13M 1.2%
Staar Surgical Co Added +80,200 +$1.95M 20.6%

Q3 2024

quarter ended September 30, 2024 · filed November 14, 2024

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Trimmed −46,080 −$10.2M 8.8%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support